Antharis Therapeutics is a biopharmaceutical company developing new treatments for cancer and neurological disorders, as well as in infectious and inflammatory diseases. Our company uses cutting-edge science to develop therapeutic monoclonal antibodies and antibody-drug conjugates with the end goal of treating unmet medical needs.
©2023 Tillat Pharmaceuticals, Inc.
PRIVACY POLICY & TERMS OF USE